Skip to main content
ORNL’s RapidCure improves lithium-ion electrode production by producing electrodes faster, reducing the energy necessary for manufacturing and eliminating the need for a solvent recycling unit. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.

Magnetic quantum material broadens platform for probing next-gen information technologies

Scientists at ORNL used neutron scattering to determine whether a specific material’s atomic structure could host a novel state of matter called a spiral spin liquid.

Researchers at Oak Ridge National Laboratory designed an adsorbent material to rapidly remove toxic chromium and arsenic simultaneously from water resources. Credit: Adam Malin/ORNL, U.S. Dept. of Energy

Researchers at ORNL are tackling a global water challenge with a unique material designed to target not one, but two toxic, heavy metal pollutants for simultaneous removal.

Innovation Crossroads Cohort Six includes: Bianca Bailey, Agriwater; Rajan Kumar, Ateois Systems; Alex Stiles, Vitriform3D; Kim Tutin, Captis Aire; Anca Timofte, Holocene Climate; and Pete Willette, facil.ai. Credit: ORNL, U.S. Dept. of Energy

Oak Ridge National Laboratory’s Innovation Crossroads program welcomes six new science and technology innovators from across the United States to the sixth cohort. 

ORNL polymer scientists Tomonori Saito, left, and Sungjin Kim upcycled waste plastic to create a stronger, tougher, solvent-resistant material for new additive manufacturing applications. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

ORNL researchers have developed an upcycling approach that adds value to discarded plastics for reuse in additive manufacturing, or 3D printing.

MDF Exterior

ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.

Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers. Credit: ORNL, U.S. Dept. of Energy

Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.

A material’s spins, depicted as red spheres, are probed by scattered neutrons. Applying an entanglement witness, such as the QFI calculation pictured, causes the neutrons to form a kind of quantum gauge. This gauge allows the researchers to distinguish between classical and quantum spin fluctuations. Credit: Nathan Armistead/ORNL, U.S. Dept. of Energy

A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.

Compression (red arrows) alters crystal symmetry (green arrows), which changes band dispersion (left and right), leading to highly mobile electrons. Credit: Jaimee Janiga, Andrew Sproles, Satoshi Okamoto/ORNL, U.S. Dept. of Energy

A team led by the ORNL has found a rare quantum material in which electrons move in coordinated ways, essentially “dancing.”

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.